U.S. RESEARCH ROUNDUP-Accolade, Costco Wholesale, RH

Reuters
01-09
U.S. RESEARCH ROUNDUP-Accolade, Costco Wholesale, RH

Jan 9 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Accolade, Costco Wholesale and RH, on Thursday.

HIGHLIGHTS

* Accolade Inc ACCD.O: Needham cuts to hold from buy

* Costco Wholesale Corp COST.O: JP Morgan cuts target price to $1,065 from $1,090

* RH RH.N: Barclays raises to overweight from equal-weight

Following is a summary of research actions on U.S. companies reported by Reuters on Thursday. Stock entries are in alphabetical order.

* Accolade Inc ACCD.O: Needham cuts to hold from buy

* Advance Auto Parts Inc. AAP.N: Barclays cuts target price to $54 from $66

* Albertsons Companies Inc ACI.N: JP Morgan cuts target price to $24 from $27

* Autozone Inc. AZO.N: Barclays raises target price to $3585 from $3024

* Best Buy Co Inc BBY.N: Barclays cuts target price to $89 from $95

* Beyond, Inc BYON.N: Barclays cuts target price to $7 from $8

* Costco Wholesale Corp COST.O: JP Morgan cuts target price to $1,065 from $1,090

* Dollar General Corporation DG.N: Barclays cuts target price to $100 from $102

* I-80 Gold Corp IAU.TO: National Bank of Canada cuts PT to C$1.75 from C$2.25

* I-80 Gold Corp IAU.TO: National Bank of Canada ups to outperform from sector perform

* I-Mab IMAB.O: Needham cuts target price to $4 from $6

* O'Reilly Automotive Inc ORLY.O: Barclays raises target price to $1110 from $1088

* RH RH.N: Barclays raises target price to $515 from $383

* RH RH.N: Barclays raises to overweight from equal-weight

* Sarepta Therapeutics Inc SRPT.O: Mizuho cuts target price to $195 from $200

* Vir Biotechnology Inc VIR.O: JP Morgan raises target price to $14 from $10

* Walmart Inc WMT.N: Barclays raises target price to $98 from $90

(Compiled by Bengaluru Newsroom)

((Diaries@thomsonreuters.com))

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10